世界のポリオ（ポリオ）ワクチン市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Polio (Poliomyelitis) Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z11096 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料

• 販売価格（消費税別）

Single User	￥504,600 (USD3,480)	▷ お問い合わせ
Multi User	￥756,900 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,009,200 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、ポリオ（ポリオ）ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ポリオ（ポリオ）ワクチンの種類別市場規模（不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV））、用途別市場規模（研究所、製薬・バイオテクノロジー企業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ポリオ（ポリオ）ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、GSK、Bibcol、Serum Institute、Tiantan Biological、IMBCA、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV） ・用途別分析2016年-2026年：研究所、製薬・バイオテクノロジー企業、その他 ・ポリオ（ポリオ）ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ポリオ（ポリオ）ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ポリオ（ポリオ）ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ポリオ（ポリオ）ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ポリオ（ポリオ）ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Polio (Poliomyelitis) Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Polio (Poliomyelitis) Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Polio (Poliomyelitis) Vaccines market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Polio (Poliomyelitis) Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)

Market segment by Application can be divided into
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others

The key market players for global Polio (Poliomyelitis) Vaccines market are listed below:
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Polio (Poliomyelitis) Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Polio (Poliomyelitis) Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market Analysis by Application
1.3.1 Overview: Global Polio (Poliomyelitis) Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Research & Academic Laboratories
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Global Polio (Poliomyelitis) Vaccines Market Size & Forecast
1.4.1 Global Polio (Poliomyelitis) Vaccines Sales in Value (2016-2026))
1.4.2 Global Polio (Poliomyelitis) Vaccines Sales in Volume (2016-2026)
1.4.3 Global Polio (Poliomyelitis) Vaccines Price by Type (2016-2026) & (USD/Unit)
1.5 Global Polio (Poliomyelitis) Vaccines Production Capacity Analysis
1.5.1 Global Polio (Poliomyelitis) Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Polio (Poliomyelitis) Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Polio (Poliomyelitis) Vaccines Market Drivers
1.6.2 Polio (Poliomyelitis) Vaccines Market Restraints
1.6.3 Polio (Poliomyelitis) Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Polio (Poliomyelitis) Vaccines Product and Services
2.1.4 Sanofi Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Polio (Poliomyelitis) Vaccines Product and Services
2.2.4 GSK Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Bibcol
2.3.1 Bibcol Details
2.3.2 Bibcol Major Business
2.3.3 Bibcol Polio (Poliomyelitis) Vaccines Product and Services
2.3.4 Bibcol Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Serum Institute
2.4.1 Serum Institute Details
2.4.2 Serum Institute Major Business
2.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Product and Services
2.4.4 Serum Institute Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Tiantan Biological
2.5.1 Tiantan Biological Details
2.5.2 Tiantan Biological Major Business
2.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Product and Services
2.5.4 Tiantan Biological Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 IMBCA
2.6.1 IMBCA Details
2.6.2 IMBCA Major Business
2.6.3 IMBCA Polio (Poliomyelitis) Vaccines Product and Services
2.6.4 IMBCA Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Panacea Biotec Ltd
2.7.1 Panacea Biotec Ltd Details
2.7.2 Panacea Biotec Ltd Major Business
2.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product and Services
2.7.4 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Bio-Med
2.8.1 Bio-Med Details
2.8.2 Bio-Med Major Business
2.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Product and Services
2.8.4 Bio-Med Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business
2.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product and Services
2.9.4 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Polio (Poliomyelitis) Vaccines Sales by Manufacturer
3.1 Global Polio (Poliomyelitis) Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Polio (Poliomyelitis) Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Polio (Poliomyelitis) Vaccines Manufacturer Market Share
3.4.2 Top 6 Polio (Poliomyelitis) Vaccines Manufacturer Market Share
3.5 Global Polio (Poliomyelitis) Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Polio (Poliomyelitis) Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Polio (Poliomyelitis) Vaccines Market Size by Region
4.1.1 Global Polio (Poliomyelitis) Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Polio (Poliomyelitis) Vaccines Revenue by Region (2016-2026)
4.2 North America Polio (Poliomyelitis) Vaccines Revenue (2016-2026)
4.3 Europe Polio (Poliomyelitis) Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Polio (Poliomyelitis) Vaccines Revenue (2016-2026)
4.5 South America Polio (Poliomyelitis) Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Polio (Poliomyelitis) Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Polio (Poliomyelitis) Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Polio (Poliomyelitis) Vaccines Revenue by Type (2016-2026)
5.3 Global Polio (Poliomyelitis) Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Polio (Poliomyelitis) Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Polio (Poliomyelitis) Vaccines Revenue by Application (2016-2026)
6.3 Global Polio (Poliomyelitis) Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Polio (Poliomyelitis) Vaccines Sales by Type (2016-2026)
7.2 North America Polio (Poliomyelitis) Vaccines Sales by Application (2016-2026)
7.3 North America Polio (Poliomyelitis) Vaccines Market Size by Country
7.3.1 North America Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Polio (Poliomyelitis) Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Polio (Poliomyelitis) Vaccines Sales by Type (2016-2026)
8.2 Europe Polio (Poliomyelitis) Vaccines Sales by Application (2016-2026)
8.3 Europe Polio (Poliomyelitis) Vaccines Market Size by Country
8.3.1 Europe Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Polio (Poliomyelitis) Vaccines Market Size by Region
9.3.1 Asia-Pacific Polio (Poliomyelitis) Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Polio (Poliomyelitis) Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Polio (Poliomyelitis) Vaccines Sales by Type (2016-2026)
10.2 South America Polio (Poliomyelitis) Vaccines Sales by Application (2016-2026)
10.3 South America Polio (Poliomyelitis) Vaccines Market Size by Country
10.3.1 South America Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Polio (Poliomyelitis) Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Polio (Poliomyelitis) Vaccines Market Size by Country
11.3.1 Middle East & Africa Polio (Poliomyelitis) Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Polio (Poliomyelitis) Vaccines Typical Distributors
12.3 Polio (Poliomyelitis) Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Polio (Poliomyelitis) Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Polio (Poliomyelitis) Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Polio (Poliomyelitis) Vaccines Product and Services
Table 6. Sanofi Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Polio (Poliomyelitis) Vaccines Product and Services
Table 10. GSK Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bibcol Basic Information, Manufacturing Base and Competitors
Table 12. Bibcol Major Business
Table 13. Bibcol Polio (Poliomyelitis) Vaccines Product and Services
Table 14. Bibcol Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 16. Serum Institute Major Business
Table 17. Serum Institute Polio (Poliomyelitis) Vaccines Product and Services
Table 18. Serum Institute Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 20. Tiantan Biological Major Business
Table 21. Tiantan Biological Polio (Poliomyelitis) Vaccines Product and Services
Table 22. Tiantan Biological Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. IMBCA Basic Information, Manufacturing Base and Competitors
Table 24. IMBCA Major Business
Table 25. IMBCA Polio (Poliomyelitis) Vaccines Product and Services
Table 26. IMBCA Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Panacea Biotec Ltd Major Business
Table 29. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Product and Services
Table 30. Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 32. Bio-Med Major Business
Table 33. Bio-Med Polio (Poliomyelitis) Vaccines Product and Services
Table 34. Bio-Med Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Halfkin Bio-Pharmaceuticals Major Business
Table 37. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Product and Services
Table 38. Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Polio (Poliomyelitis) Vaccines Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Polio (Poliomyelitis) Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Polio (Poliomyelitis) Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Polio (Poliomyelitis) Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Polio (Poliomyelitis) Vaccines Production Site of Key Manufacturer
Table 44. Global Polio (Poliomyelitis) Vaccines Sales by Region (2016-2021e) & (K Units)
Table 45. Global Polio (Poliomyelitis) Vaccines Sales by Region (2021-2026) & (K Units)
Table 46. Global Polio (Poliomyelitis) Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Polio (Poliomyelitis) Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Polio (Poliomyelitis) Vaccines Sales by Type (2016-2021e) & (K Units)
Table 49. Global Polio (Poliomyelitis) Vaccines Sales by Type (2021-2026) & (K Units)
Table 50. Global Polio (Poliomyelitis) Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Polio (Poliomyelitis) Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Polio (Poliomyelitis) Vaccines Price by Type (2016-2021e) & (USD/Unit)
Table 53. Global Polio (Poliomyelitis) Vaccines Price by Type (2021-2026) & (USD/Unit)
Table 54. Global Polio (Poliomyelitis) Vaccines Sales by Application (2016-2021e) & (K Units)
Table 55. Global Polio (Poliomyelitis) Vaccines Sales by Application (2021-2026) & (K Units)
Table 56. Global Polio (Poliomyelitis) Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Polio (Poliomyelitis) Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Polio (Poliomyelitis) Vaccines Price by Application (2016-2021e) & (USD/Unit)
Table 59. Global Polio (Poliomyelitis) Vaccines Price by Application (2021-2026) & (USD/Unit)
Table 60. North America Polio (Poliomyelitis) Vaccines Sales by Country (2016-2021e) & (K Units)
Table 61. North America Polio (Poliomyelitis) Vaccines Sales by Country (2021-2026) & (K Units)
Table 62. North America Polio (Poliomyelitis) Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Polio (Poliomyelitis) Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Polio (Poliomyelitis) Vaccines Sales by Type (2016-2021e) & (K Units)
Table 65. North America Polio (Poliomyelitis) Vaccines Sales by Type (2021-2026) & (K Units)
Table 66. North America Polio (Poliomyelitis) Vaccines Sales by Application (2016-2021e) & (K Units)
Table 67. North America Polio (Poliomyelitis) Vaccines Sales by Application (2021-2026) & (K Units)
Table 68. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Polio (Poliomyelitis) Vaccines Sales by Country (2021-2026) & (K Units)
Table 70. Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Polio (Poliomyelitis) Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Polio (Poliomyelitis) Vaccines Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Polio (Poliomyelitis) Vaccines Sales by Type (2021-2026) & (K Units)
Table 74. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Polio (Poliomyelitis) Vaccines Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Polio (Poliomyelitis) Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Polio (Poliomyelitis) Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales by Application (2021-2026) & (K Units)
Table 84. South America Polio (Poliomyelitis) Vaccines Sales by Country (2016-2021e) & (K Units)
Table 85. South America Polio (Poliomyelitis) Vaccines Sales by Country (2021-2026) & (K Units)
Table 86. South America Polio (Poliomyelitis) Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Polio (Poliomyelitis) Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Polio (Poliomyelitis) Vaccines Sales by Type (2016-2021e) & (K Units)
Table 89. South America Polio (Poliomyelitis) Vaccines Sales by Type (2021-2026) & (K Units)
Table 90. South America Polio (Poliomyelitis) Vaccines Sales by Application (2016-2021e) & (K Units)
Table 91. South America Polio (Poliomyelitis) Vaccines Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Polio (Poliomyelitis) Vaccines Typical Distributors
Table 103. Polio (Poliomyelitis) Vaccines Typical Customers
List of Figures
Figure 1. Polio (Poliomyelitis) Vaccines Picture
Figure 2. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type in 2020
Figure 3. Inactivated Polio Vaccine (IPV)
Figure 4. Oral Polio Vaccine (OPV)
Figure 5. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application in 2020
Figure 6. Research & Academic Laboratories
Figure 7. Pharmaceutical & Biotechnology Companies
Figure 8. Others
Figure 9. Global Polio (Poliomyelitis) Vaccines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Polio (Poliomyelitis) Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Polio (Poliomyelitis) Vaccines Sales (2016-2026) & (K Units)
Figure 31. Global Polio (Poliomyelitis) Vaccines Production Capacity (2016-2026) & (K Units)
Figure 32. Global Polio (Poliomyelitis) Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Polio (Poliomyelitis) Vaccines Market Drivers
Figure 34. Polio (Poliomyelitis) Vaccines Market Restraints
Figure 35. Polio (Poliomyelitis) Vaccines Market Trends
Figure 36. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Manufacturer in 2020
Figure 37. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Manufacturer in 2020
Figure 38. Polio (Poliomyelitis) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Polio (Poliomyelitis) Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Polio (Poliomyelitis) Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2016-2026)
Figure 42. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2016-2026)
Figure 43. North America Polio (Poliomyelitis) Vaccines Revenue (2016-2026) & (USD Million)
Figure 44. Europe Polio (Poliomyelitis) Vaccines Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Polio (Poliomyelitis) Vaccines Revenue (2016-2026) & (USD Million)
Figure 46. South America Polio (Poliomyelitis) Vaccines Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue (2016-2026) & (USD Million)
Figure 48. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2016-2026)
Figure 49. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Type (2016-2026)
Figure 50. Global Polio (Poliomyelitis) Vaccines Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2016-2026)
Figure 52. Global Polio (Poliomyelitis) Vaccines Revenue Market Share by Application (2016-2026)
Figure 53. Global Polio (Poliomyelitis) Vaccines Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Polio (Poliomyelitis) Vaccines Sales Market Share by Country (2016-2026)
Figure 55. North America Polio (Poliomyelitis) Vaccines Revenue Market Share by Country (2016-2026)
Figure 56. North America Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2016-2026)
Figure 57. North America Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2016-2026)
Figure 58. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Country (2016-2026)
Figure 59. Europe Polio (Poliomyelitis) Vaccines Revenue Market Share by Country (2016-2026)
Figure 60. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2016-2026)
Figure 61. Europe Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2016-2026)
Figure 66. South America Polio (Poliomyelitis) Vaccines Sales Market Share by Country (2016-2026)
Figure 67. South America Polio (Poliomyelitis) Vaccines Revenue Market Share by Country (2016-2026)
Figure 68. South America Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2016-2026)
Figure 69. South America Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Polio (Poliomyelitis) Vaccines Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source

---